VERTEX PHARMACEUTICALS INC / MA: accounts_receivable
| Value | {"amount": 3548000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2010-06-30) |
| Status | current |
| Entity | VERTEX PHARMACEUTICALS INC / MA |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:42:16.115598+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/f852ba03-c99a-4920-ae21-0c203517ecd6
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001047469-10-006916Retrieved: 2026-08-19T08:42:16.115598+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000875320/accounts-receivable/2010-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/f852ba03-c99a-4920-ae21-0c203517ecd6
History
- no predecessors — first report